Skip to content
10-Q

Quarterly Report

Ibere Pharmaceuticals

0001104659-21-106493

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Short Term Debt Q2 2021 · Jun 30, 2021 $0
Cash And Equivalents Q2 2021 · Jun 30, 2021 $855.81K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $175.37K
Current Liabilities Q2 2021 · Jun 30, 2021 $209.14K
Current Liabilities Q2 2021 · Dec 31, 2020 $657.13K
Total Liabilities Q2 2021 · Jun 30, 2021 $14.12M
Total Liabilities Q2 2021 · Dec 31, 2020 $657.13K
Current Assets Q2 2021 · Jun 30, 2021 $1.21M
Current Assets Q2 2021 · Dec 31, 2020 $175.37K
Total Assets Q2 2021 · Jun 30, 2021 $139.21M
Total Assets Q2 2021 · Dec 31, 2020 $676.37K